Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 10Terminated 5Recruiting 3Unknown 2Active not recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 33NIH 25INDUSTRY 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Injections 54Cisplatin 49Paclitaxel 48Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 36Capecitabine 36Drug Therapy 34anlotinib 25Bevacizumab 25Fluorouracil 24icotinib 23Cyclophosphamide 23Oxaliplatin 20fludarabine 18Pemetrexed 17Leucovorin 16Irinotecan 16Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Ifosfamide × Clear all
NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

BeBetter Med Inc

Phase 1 Unknown
75 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00718484 2014-01-30

PICASSO

Alaunos Therapeutics

Phase 2 Unknown
67 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡